Institutional investors hold a majority ownership of LLY through the 66.43% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended June 2016, these large investors purchased a net $7.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JANUS CAPITAL MANAGEMENT LLC Bought 2.5 Million shares of Eli Lilly and Co
GOLDMAN SACHS ASSET MANAGEMENT L... Bought 2.4 Million shares of Eli Lilly and Co
EATON VANCE MANAGEMENT Bought 2.3 Million shares of Eli Lilly and Co